PuSH - Publikationsserver des Helmholtz Zentrums München

Mycielska, M.E.* ; Mohr, M.T.J.* ; Schmidt, K.* ; Drexler, K.* ; Ruemmele, P.* ; Haferkamp, S.* ; Schlitt, H.J.* ; Gaumann, A.* ; Adamski, J. ; Geissler, E.K.*

Potential use of gluconate in cancer therapy.

Front. Oncol. 9:522 (2019)
Verlagsversion DOI
Open Access Gold
Creative Commons Lizenzvertrag
We have recently discovered that cancer cells take up extracellular citrate through plasma membrane citrate transporter (pmCiC) and advantageously use citrate for their metabolism. Citrate uptake can be blocked with gluconate and this results in decreased tumor growth and altered metabolic characteristics of tumor tissue. Interestingly, gluconate, considered to be physiologically neutral, is incidentally used in medicine as a cation carrier, but not as a therapeutically active substance. In this review we discuss the results of our recent research with available literature and suggest that gluconate may be useful in the treatment of cancer.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Cancer Metabolism ; Citrate ; Gluconate ; Metabolic Targeting ; Transporter; Sodium Stibogluconate; Magnesium Infusions; Phase-ii; In-vitro; Disulfiram; Prevention; Antimony; Calcium; Cells; Immunotherapy
ISSN (print) / ISBN 2234-943X
e-ISSN 2234-943X
Zeitschrift Frontiers in Oncology
Quellenangaben Band: 9, Heft: , Seiten: , Artikelnummer: 522 Supplement: ,
Verlag Frontiers
Verlagsort Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland
Begutachtungsstatus Peer reviewed
Institut(e) Molekulare Endokrinologie und Metabolismus (MEM)